US Stock MarketDetailed Quotes
HRTX Heron Therapeutics
- 1.070
- +0.010+0.94%
Close Nov 22 16:00 ET
- 1.100
- +0.030+2.80%
Post 20:01 ET
162.74MMarket Cap-6687P/E (TTM)
1.100High1.060Low1.34MVolume1.080Open1.060Pre Close1.45MTurnover1.16%Turnover RatioLossP/E (Static)152.09MShares3.93052wk High-4.07P/B123.05MFloat Cap1.04052wk Low--Dividend TTM115.00MShs Float830.000Historical High--Div YieldTTM3.77%Amplitude0.500Historical Low1.080Avg Price1Lot Size
About Heron Therapeutics Company
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.
Company Profile
SymbolHRTX
Company NameHeron Therapeutics
Listing DateJan 23, 2014
Issue Price7.00
Founded1983
CEOMr. Craig A. Collard
MarketNASDAQ
Employees126
Fiscal Year Ends12-31
Address4242 Campus Point Court,Suite 200
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-251-4400
Websitehttp://www.herontx.com
Company Executives
- Name
- Position
- Salary
- Craig A. Collard
- Director and Chief Executive Officer
- 10.78M
- Ira Duarte
- Chief Accounting Officer, Executive Vice President and Chief Financial Officer
- 1.53M
- Dr. William P. Forbes
- Executive Vice President and Chief Development Officer
- 1.46M
- Adam Morgan
- Chairman of the Board
- 545.53K
- Michael Kaseta
- Director
- --
- Dr. Sharmila Dissanaike, F.A.C.S.,M.D.
- Independent Director
- 55.00K
- Christian Waage
- Independent Director
- 70.51K
- Susan Rodriguez
- Independent Director
- 65.63K
- Craig A. Johnson
- Independent Director
- 79.03K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data